| N/A | Gene mutations in non-smoking female lung cancer patients with adenocarcinoma | 240000 | 1993 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| N/A | Japan-Hong Kong lung cancer study | 524470 | 1985 | Co-Investigator | | Professor Ho John Hung Chiu | Co-Investigator | | null |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| N/A | Gene mutations in non-smoking female lung cancer patients with adenocarcinoma | 240000 | 1994 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| N/A | Gene mutations in non-smoking female lung cancer patients with adenocarcinoma | 240000 | 1995 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| N/A | Gene mutations in non-smoking female lung cancer patients with adenocarcinoma | 240000 | 1990 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| N/A | Gene mutations in non-smoking female lung cancer patients with adenocarcinoma | 240000 | 1992 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| N/A | p21-activated kinase 4: a prognostic and therapeutic target for ovarian carcinoma? | 296137 | 2007 | Co-Investigator | | | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| N/A | Cultural, environmental and familial backgrounds of female lung cancer patients and controls in Hong Kong | 1500000 | 1993 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| 21005975 | Differential expression of tumor-derived exosomal microRNAs from the plasma of breast cancer patients: A potential biomarker for breast cancer screening | 196880 | 2009 | Co-principal investigator | | | Co-Investigator | | Dr Suen To Ki Dacita |
| Co-Principal Investigator (Co-PI) (for projects led by other university) | | |
|
| N/A | In-vitro combination of arsenic trioxide and chemotherapy in non-small cell lung cancer | 157202 | 2010 | | Principal Investigator (PI) | | |
|
| N/A | Genetic and environmental risk factors and their interaction in the pathogenesis of lung cancer in Hong Kong | 450000 | 2000 | Co-Investigator | | Emeritus Professor Lam Wah Kit | Co-Investigator | | |
| Principal Investigator (PI) | | Professor Chan, Moira Mo Wah |
|
| N/A | Combine targeted therapy with chemotherapy for liver cancer treatment | 200000 | 2007 | Co-Investigator | | Dr Ho Jenny Chung Yee | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| AR150032 | In Vitro and in vivo combination of arginase and chemotherapeutic drugs in squamous cell lung carcinoma | 179465 | 2015 | | Principal Investigator (PI) | | Dr Lam, Sze Kwan |
|
| AR180052 | Assessment of the effect of transarterial embolization on treatment response and drug resistance in Hepatocellular Carcinoma (HCC) receiving tyrosine kinase inhibitors using preclinical microPET/MRI system | 200000 | 2018 | Co-Investigator | | | Co-Investigator | | Dr Yuan Hui | Co-Investigator | | |
| Principal Investigator (PI) | | |
|
| N/A | Gene mutations in non-smoking female lung cancer patients with adenocarcinoma | 240000 | 1991 | Co-Investigator | | Professor Ho John Hung Chiu |
| Principal Investigator (PI) | | Dr Koo, Linda Chih Ling |
|
| AR190027 | Predicting responses and monitoring disease evolution in myelodysplastic syndrome (MDS) using next-generation sequencing (NGS) | 206724 | 2018 | | Principal Investigator (PI) | | |
|
